[14C]TGRX-326
TGRX-326-1004
Phase 1 small_molecule completed
Quick answer
[14C]TGRX-326 for Non Small Cell Lung Cancer is a Phase 1 program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- First Tracks Biotherapeutics
- Indication
- Non Small Cell Lung Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed